Navigation Links
LA Laker Pau Gasol Introduces New Technology Donated by Grifols to Pharmacy at Children's Hospital Los Angeles
Date:3/26/2012

LOS ANGELES, March 26, 2012 /PRNewswire/ -- Los Angeles Lakers' power forward Pau Gasol has partnered with Grifols, a Barcelona-based global health care company with U.S. headquarters in Los Angeles, to bring new technology to the pediatric pharmacy at Children's Hospital Los Angeles. The new Phocus Rx system will automate quality control oversight during the preparation of pediatric medications. "It's a win-win-win for Children's Hospital Los Angeles, for Grifols and for patient and families," said Gasol.

A charitable donation from Grifols, the Phocus Rx system is designed to enhance the safety of compounding medicines while also improving efficiency and workflow in the sterile compounding pharmacy at Children's Hospital Los Angeles. The equipment visualizes and records pharmacy compounding procedures so that pharmacists can remotely validate the pharmacy technician's activity and ensure its accuracy.

Gasol facilitated the donation through his personal connections with both Children's Hospital Los Angeles and Grifols, a company based in his native city of Barcelona. As a former pre-med student with a strong interest in medicine, Gasol is a frequent visitor and champion for Children's Hospital Los Angeles, where he observed spinal surgery in 2010.

"Just as teamwork is critical in sports, I think it is essential to form partnerships between businesses, nonprofits and government agencies," said Gasol. "Pairing Grifols with Children's Hospital Los Angeles seemed like a natural fit, and I was happy to bridge the connection." 

As a pediatric hospital that treats many children who have rare and serious illnesses, Children's Hospital Los Angeles tailors its treatments to the unique medical needs of each patient, said Carol Taketomo, director of Pharmacy at Children's Hospital Los Angeles.

"In order to make sure that the right medication gets to the right patient at the correct dose, we have a required process of checks and double checks," said Taketomo. The Grifols Phocus Rx system adds an additional measure of safety. We are excited to have new technology that enhances our workflow efficiency and serves as an important quality-control check in our pharmacy validation process."

In addition to Phocus Rx, Grifols will donate an inventory management system to the hospitals' pharmacy infusion center that will automate the cataloguing and inventory control of medicines and compounds, thereby enhancing efficiency and speeding the delivery of prescriptions to pediatric patients.

About Grifols

Grifols, S.A. is a global healthcare company that specializes in the pharmaceutical and hospital sectors. Headquartered in Barcelona, Spain, Grifols has a presence in more than 100 countries and is the third largest global producer of therapies derived from human plasma. A vertically integrated company, Grifols is the world leader in plasma collection, with 147 plasma donation centers across the United States. Grifols owns and operates three state-of-the-art manufacturing facilities in California (Los Angeles), North Carolina and Spain, allowing the company to respond to the growing market demand for plasma-derived therapies.

Since 2006, the ordinary shares of Grifols (class A) have been quoted on the Mercado Continuo Espanol and since 2008 they have been on the Ibex-35 (GRF). Starting in June 2011, the non-voting shares of Grifols (class B) were also quoted on the Mercado Continuo (GRF.P) and on the U.S. NASDAQ (GRFS) through ADRs (American Depository Receipts).

About Children's Hospital Los Angeles

Children's Hospital Los Angeles has been named the best children's hospital in California and among the best in the nation for clinical excellence with its selection to the prestigious US News & World Report Honor Roll.  Children's Hospital is home to The Saban Research Institute, one of the largest and most productive pediatric research facilities in the United States. The hospital is also one of America's premier teaching hospitals through its affiliation since 1932 with the Keck School of Medicine of the University of Southern California.

For more information, visit CHLA.org. Follow us on Twitter, Facebook, YouTube and LinkedIn, or visit our blog: WeAreChildrens.org.


'/>"/>
SOURCE Grifols
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children
2. Dr. Dello Russo Introduces the New EYE-Q Lasik
3. Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds
4. Wedgewood Introduces Refresh(TM) Exchange-Program: Free Exchange of Expired Veterinary Compounded Medications Solves Key Industry Problem
5. CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
6. Thermo Fisher Scientific Introduces Breakthrough in RNA-Interference Technology
7. Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
8. Siemens Introduces New Standard of Care for Breast Ultrasound
9. Perceptive Informatics Introduces Medical Imaging Methodology to Accelerate Development Decisions About Alzheimers Treatments
10. Quest Diagnostics Introduces First Commercial Laboratory Test for Identifying the H1N1 Swine Flu Virus
11. VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Bracket , a leading clinical trial ... clinical outcomes platform, Bracket eCOA (SM) 6.0, at the ... – 30, 2016 in Philadelphia , Pennsylvania.  ... Assessment product of its kind to fully integrate with RTSM, ... eCOA 6.0 is a flexible platform for electronic clinical outcomes ...
(Date:6/23/2016)... announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia ... ... ... ... Astellas is a pharmaceutical ...
(Date:6/23/2016)... 2016 The vast majority of dialysis patients ... Treatments are usually 3 times a week, with treatment ... travel time, equipment preparation and wait time.  This regimen ... for patients who are elderly and frail.  Many elderly ... rehabilitation centers for some duration of time. ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, ... remain in the eye of the beholder, according to experts who offered insights and ... Journal of Managed Care. For the full issue, click here . , For ...
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):